ANIMAL HEALTH INDUSTRY NEWS-Sept.

Apiam Animal Health reported a 6.2% revenue growth to A$205 million for 2024, while Elanco Southern Cone is launching CASA to enhance regional support and innovation in pet care under Juan Pablo Zingoni’s leadership. Boehringer Ingelheim has acquired Saiba Animal Health AG for chronic pet disease treatments, secured UK approval for a new bluetongue vaccine, and announced a strategic partnership in India. Mars Petcare is collaborating on a Next Generation Pet Food Program focusing on sustainable ingredients. Patterson Companies experienced a 2.8% decline in Animal Health segment sales, Phibro Animal Health achieved a 4% increase in net sales with a 7% rise in Animal Health sales, and Phibro Saúde Animal Brasil is organizing a ‘Beef Tour’ across Brazil and Argentina with international participants.

#animalhealth #business #latinamerica #regulatoryaffairs #bernardootero #nexus

?? Apiam Animal Health reported results for its full year 2024. Revenue grew 6.2% to A$205 million (US$139 million). Gross profit was A$137.3 million (US$93 million), an increase of 9.6%. (petnews.com.au).

?? The largest small animal veterinary event in Latin America took place in Mexico. The Congress of León Veterinary (CVDL), which will be replicated next year in Florida, USA; Valencia, Venezuela; Honduras; and Tarragona, Spain, was a success. César Morales Torres, General Director of the Congress, highlighted this achievement during the opening of the 29th edition of CVDL, held from September 4 to 7 at the Poliforum León. The event attracted 20,000 attendees, including veterinarians and students. This year's theme was Harry Potter, featuring 800 conferences with 200 sessions held simultaneously in 30 rooms. Visitors came from 15 countries, and the exhibition floor had 900 stands. (am.com.mx, Sept.).

?? Elanco Southern Cone announces the launch of the new affiliate CASA (Central and South America). The launch under the leadership of Juan Pablo Zingoni will provide a more regional approach to its clients, enhancing reach and technical capability. At Elanco CASA, innovation and the development of advanced solutions will be promoted to address challenges in health, well-being, profitable and sustainable production, and global food security, while helping clients care for their pets, aiming to improve their health, quality of life, and longevity. (Linkedin, Sept).

?? In Brazil, Ourofino aims to activate the official capacity of its plant following the official decision to stop vaccinating against foot-and-mouth disease. Joseph Harvey, Director of Animal Health at "Ourofino Saúde Animal" in Brazil, is scheduling numerous product launches for food animals and pets. The company's CEO, Kleber Gomes, said that national authorities approved two vaccines for animals destined for human consumption and that they will be launched commercially soon. Additionally, Ourofino recently launched so-called "thermal analogs" to reduce stress in pigs and cattle. This technology was developed exclusively in partnership with an anonymous U.S. company. (agritotal.com, Aug.).

?? Biogénesis Bagó Argentina is investing around US$50 million this year in the new plant in the country. It is now the leading biotech in animal health in the region and a 'jewel' that continues to gain recognition from its shareholders. Esteban Turic has led the company for five years, during which the company grew at 14% annually in a market that was growing at 3%. (El Cronista, Sept.).

?? Mirgor enters the pork business with Ingacot S.A. Agustin Tocagni, manager of INGACOT S.A., and Agustin Ayerza, executive manager of agro-industry at Mirgor Group, were present at the Argentina 2024 Pork Business Meeting (EEPA). The pork business offers scalability for these two companies, with INGACOT S.A. currently having 3,850 sows and, thanks to the partnership with Mirgor, its master plan will increase to 6,050 sows. This will enhance both companies and open up opportunities for sustainable industry development. (3tres3.com, Sept.).

?? The FDA announced the approval of Coxidin 90 (generic monensin Type A medicated article) for use in poultry and quail. (FDA).

?? The FDA announced the approval of Pharmgate's MGA and Deracin (generic melengestrol acetate Type A medicated article and chlortetracycline Type A medicated article) for use in beef and dairy heifers. (FDA).

?? The International Veterinary Congress of Iguazú will be held in October. The International Veterinary Congress of Iguazú (CIVI) will take place on October 4 and 5 in Misiones. National and international speakers will address public health and prevention of zoonoses. Speakers will cover current topics related to public health and the prevention of zoonotic diseases at the next edition of the International Veterinary Congress of Iguazú (CIVI), which will be held on October 4 and 5 at the Iguazú Events and Convention Center, in Puerto Iguazú, Misiones. (motivar.com.ar, Aug.).

?? Chile leads participation in Benchmark Animal Health’s global survey on sea lice control. Benchmark Animal Health continues its commitment to continuous improvement through feedback from its users on sea lice control. Annually, the company conducts a global survey involving fish health professionals, operations, animal welfare, and the environment in key countries such as Chile, Canada, the UK, and Iceland. This survey aims to refine control strategies and optimize the use of products such as Purisan? and Salmosan Vet?. (mundoacuicola.cl, Sept 5th).

?? Boehringer Ingelheim announced it has acquired Saiba Animal Health AG, a company focused on the development of novel therapeutic medicines to address chronic diseases in pets. Saiba Animal Health’s technology platform uses a therapeutic vaccine approach designed to create an immune response, targeting chronic diseases such as allergy, inflammation, and pain. Financial terms were not disclosed. (company press release).

?? Boehringer Ingelheim India announced a strategic distribution partnership with Vvaan Lifesciences Private Limited for its Pet Parasiticide portfolio. The partnership leverages Vvaan Lifesciences' expertise to extend the reach of Boehringer's pet portfolio in Tier 2 cities (mini metros) and expand its customer base in underserved regions. (company press release).

?? Boehringer Ingelheim receives UK permit for new vaccine against bluetongue virus serotype 3 in sheep and cattle. BULTAVO 3? is a new vaccine indicated for the active immunization of sheep and cattle against bluetongue virus serotype 3 (BTV-3). Recent outbreaks of BTV-3 across Europe and in Great Britain have the potential to cause serious losses for farmers. The vaccine has been permitted for use in the UK, initially in high-risk counties (as defined by Defra). (Company site, Sept. 4th).

?? Mars Petcare announced a partnership with Big Idea Ventures to launch the Next Generation Pet Food Program. The pilot initiative, in collaboration with AAK (specializing in plant-based vegetable oils and fats) and Bühler (a global technology partner for the food, feed, and mobility industries), is looking for startups working on sustainable protein and fat that can support pathways to reducing carbon emissions in pet food production. This includes novel ingredients and processing technologies, such as upcycling food waste and innovative extraction methods. (petfood industry).

?? Norbrook Laboratories Ltd of Northern Ireland announced the appointment of Brian Hopkins to the role of US VP Regional Sales and Marketing. Brian is a seasoned leader in the Animal Health industry and brings a wealth of industry knowledge and a passion for developing exceptional team culture to the Norbrook business. Hopkins has experience as Executive Director in Elanco and will bring network and experience to be instrumental in propelling Norbrook into its next phase of growth. (Company's Linkedin, Sept.).

?? Patterson Companies, Inc. reported results for its fiscal 2025 first quarter ended July 27, 2024. Reported net sales in the Animal Health segment were $982.4 million, a year-over-year decline of 2.8%. Segment operating income was $25.4 million, a decline of 15%. (company press release).

?? Patterson Veterinary Supply, Inc. announced the addition of pute.us to its product offering portfolio. pute.us is a provider of both hardware – including printers, security cameras, and phones – and managed concierge IT services for veterinary practices nationwide. (company press release).

?? Phibro Animal Health Corporation announced financial results for its fiscal year ended June 30, 2024. Net sales were $1,018 million, an increase of 4%. Net income was $2.4 million, a decrease of $30.2 million. Animal Health net sales were $706.5 million, an increase of 7%, and Animal Health adjusted EBITDA was $145.6 million, an increase of 7%. (company website).

?? Phibro Saúde Animal Brasil is conducting a ‘Beef Tour’ across Brazil and Argentina. The exclusive event will see partners, clients, and collaborators visiting feedlots, slaughterhouses, and participating in technical meetings. It will be a week-long event across Brazil and Argentina. In addition to Brazilians and Argentinians, the group includes Australians and South Africans. The group will visit feedlot units and slaughterhouses in Goiás and participate in a technical meeting on bovine oral health at the Federal University of Goiás (UFG) with Professor Dr. Ana Carolina Borsanelli. (jornaldiadia.com.br, Sept. 8th).

?? DOMINICAN REPUBLIC: Dr. Eduardo Brea Tió has assumed the role of new director of the Central Veterinary Laboratory (LAVECEN). Brea Tió expressed his commitment to strengthening quality standards in animal and human health, as well as in food safety, according to national and international regulations. With a distinguished professional background in Veterinary Medicine and Agronomy, Brea Tió graduated from the Instituto Superior de Agricultura (ISA) in Agronomy and from the Autonomous University of Santo Domingo (UASD) in Veterinary Medicine.

Follow us ?? BERNARDO OTERO Animal Health Leadership in LATIN AMERICA.

CEO & Founder of NEXUS ANIMAL HEALTH

SUBSCRIBE HERE ?? Subscribe on LinkedIn https://www.dhirubhai.net/build-relation/newsletter-follow?entityUrn=6862344212038328321